Home › Attention Deficit Hyperactivity Disorder › Georgia › Atlanta
Attention Deficit Hyperactivity Disorder clinical trials in Atlanta, GA
5 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Emory University (Children's Healthcare of Atlanta), Atlanta
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Atlanta
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Atlanta
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
RecruitingPhase 2
- Alkermes Investigational Site, Decatur · 6 mi away
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Advanced Discovery Research LLC, Atlanta
- Clinical Integrative Research Center of Atlanta, Atlanta
- CenExcel iResearch, LLC, Decatur · 6 mi away
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Jacksonville, FL5 studies
- Baltimore, MD4 studies
- Los Angeles, CA4 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer48 studies
- Multiple Myeloma42 studies
- Breast Cancer42 studies
- Prostate Cancer36 studies
- Acute Myeloid Leukemia30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer28 studies
- Obesity26 studies
- Major Depressive Disorder24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.